New natural variants of hepatitis B virus among Amerindians from Argentina with mainly occult infections

Journal of Clinical Virology

Volumn 54, Issue 2, 2012, Pages 174-179

  Delfino, Cecilia M ^a,b   Berini, Carolina ^a   Eirin, María E ^a   Malan, Richard ^c   Pedrozo, Williams ^c   Krupp, Ramón ^c   Blejer, Jorgelina ^d   Espejo, Rogelio ^e   Fierro, Leopoldo ^e   Puca, Alberto ^f   Oubiña, José R ^b   Mathet, Verónica L ^b   Biglione, Mirna M ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Universidad de Buenos Aires   (Argentina)

^c Central Blood Bank of Misiones Province   (Argentina)

^d HOSPITAL UNIVERSITARIO FUNDACIÓN FAVALORO   (Argentina)

^e Hospital Privado del Colegio Médico de San Juan Ciudad de San Juan   (Argentina)

^f AA Puca Laboratory   (Argentina)

Author keywords

Amerindians; Hepatitis B virus; Natural variants; Occult hepatitis B infection; Subgenotypes

Indexed keywords

ADEFOVIR; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN; LAMIVUDINE; VIRUS DNA;

ADULT; AGED; AMERICAN INDIAN; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIBODY DETECTION; ANTIGEN DETECTION; ANTIVIRAL RESISTANCE; ARGENTINA; ARTICLE; CROSS-SECTIONAL STUDY; DNA POLYMORPHISM; ETHNICITY; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCULT HEPATITIS B; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS GENE;

ADOLESCENT; ADULT; AGED; ARGENTINA; CLUSTER ANALYSIS; CROSS-SECTIONAL STUDIES; DNA, VIRAL; FEMALE; GENETIC VARIATION; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; INDIANS, SOUTH AMERICAN; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; SEQUENCE ANALYSIS, DNA; VIRAL PROTEINS; YOUNG ADULT;

EID: 84860331054     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2012.02.023     Document Type: Article

References (42)

1. El-Serag H., Ruldolph K. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007, 132(7):2557-2576. [PubMed: 17570226].
2. Mathet V., Cuestas M.L., Trinks J., Minassian M.L., Ruiz V., Rivero C.W., et al. Genetic diversity and variability of Hepatitis B virus (HBV) in Latin America and the Caribbean region: Implications in epidemiological, clinical, diagnostic, prophylactic and therapeutic approaches. Progress in hepatitis B 2007, 277-351. Nova Science Publishers Inc, NY, USA, [chapter X]. D.V. Denyer (Ed.).
3. McMahon B.J. The natural history of chronic hepatitis B virus infection. Hepatology 2009, 49:45-55. [PubMed: 19399792].
4. Tatematsu K., Tanaka Y., Kurbanov F., Sugauchi F., Mano S., Maeshiro T., et al. A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J. J Virol 2009, 83:10538-10547. [PubMed: 19640977].
5. World Health Organization (WHO). Fact sheet No. 204. Revised August 2008. http://www.who.int/mediacentre/factsheets/fs204/en/.
6. Torbenson M., Thomas D.L. Occult hepatitis B infection. Lancet Infect Dis 2002, 2:479-486. [PubMed: 12150847].
7. Roman S., Tanaka Y., Khan A., Kurbanov F., Kato H., Mizokami M., et al. Occult hepatitis B in the genotype H-infected Nahuas and Huichol native Mexican population. J Med Virol 2010, 82:1527-1536. [PubMed: 20648606].
8. Devesa M., Pujol F., Hepatitis B virus genetic diversity in Latin America. Virus Res 2007, 127:177-184. [PubMed: 17280734].
9. Proyecto Programa Nacional de control de Hepatitis Virales. Epidemiología Informe No 6(2006), 8(2008), 9(2009). Instituto Nacional de Enfermedades Infecciosas (INEI). Administración Nacional de Laboratorios e Institutos de Salud (ANLIS) " Dr. Carlos Gregorio Malbrán" http://www.hepatitisviral.com.ar/ppnhv.htm.
10. Trinks J., Cuestas M.L., Tanaka Y., Mathet V.L., Minassian M.L., Rivero C.W., et al. Two simultaneous hepatitis B virus epidemics among injecting drug users and men who have sex with men in Buenos Aires, Argentina: characterization of the first D/A recombinant from the American continent. J Viral Hepat 2008, 15:827-838. [PubMed: 18507755].
11. Franca P.H., González J.E., Munne M.S., Brandao L.H., Gouvea V.S., Sablon E., et al. Strong association between genotype F and hepatitis B virus (HBV) e antigen-negative variants among HBV-infected Argentinean blood donors. J Clin Microbiol 2004, 42:5015-5021. [PubMed: 15528689].
12. Piñeiro Y.L.F.G., Pezzano S.C., Torres C., Rodríguez C.E., Eugenia Garay M., Fainboim H.A., et al. Hepatitis B virus genetic diversity in Argentina: dissimilar genotype distribution in two different geographical regions; description of hepatitis B surface antigen variants. J Clin Virol 2008, 42:381-388. [PubMed: 18479961].
13. Mathet V.L., Cuestas M.L., Ruiz V., Minassian M.L., Rivero C., Trinks J., et al. Detection of hepatitis B virus (HBV) genotype E carried - even in the presence of high titers of anti-HBs antibodies - by an Argentinean patient of African descent who had received vaccination against HBV. J Clin Microbiol 2006, 44:3435-3439. [PubMed: 16954295].
14. Flichman D., Galdame O., Livellara B., Viaut M., Gadano A., Campos R. Full-length genome characterization of hepatitis B virus genotype H strain isolated from serum samples collected from two chronically infected patients in Argentina. J Clin Microbiol 2009, 47:4191-4193. [PubMed: 19794035].
15. Quarleri J., Moretti F., Bouzas M.B., Laufer N., Carrillo M.G., Giuliano S.F., et al. Hepatitis B virus genotype distribution and its lamivudine-resistant mutants in HIV-coinfected patients with chronic and occult hepatitis B. AIDS Res Hum Retroviruses 2007, 23(4):525-531. [PubMed: 17506609].
16. Magrassi G.E. Los aborígenes de la Argentina. Ensayo socio-histórico-cultural 1987, Ed. Galerna-Búsqueda de Ayllu, Buenos Aires, Argentina, pp. 1-128, ISBN: 950-560-037-2.
17. Zeng G.B., Wen S.J., Wang Z.H., Yan L., Sun J., Hou J.L. A novel hepatitis B virus genotyping system by using restriction fragment length polymorphism patterns of S gene amplicons. World J Gastroenterol 2004, 10:3132-3136. [PubMed: 15457558].
18. Birkenmeyer L., Mushahwar I. Detection of hepatitis A, B and D virus by the polymerase chain reaction. J Virol Methods 1994, 49:101-112. [PubMed: 7822452].
19. Sugauchi F., Mizokami M., Orito E., Ohno T., Kato H., Suzuki S., et al. A novel variant genotype C of hepatitis B virus identified in isolates from Australian Aborigines: complete genome sequence and phylogenetic relatedness. J Gen Virol 2001, 82:883-892. [PubMed: 11257194].
20. Thompson J.D., Gibson T.J., Plewniak F., Jeanmougin F., Higgins D.G. The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 1997, 25:4876-4882. [PubMed: 9396791].
21. Tamura K., Dudley J., Nei M., Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 2007, 24:1596-1599. [PubMed: 17488738].
22. Norder H., Courouce A., Coursaget P., Echevarría J., Lee S., Mushahwar I., et al. Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology 2004, 47:289-299. [PubMed: 15564741].
23. Warner N., Locarnini S., Kuiper M., Bartholomeusz A., Ayres A., Yuen L., et al. The L80I substitution in the reverse transcriptase domain of the hepatitis B virus polymerase is associated with lamivudine resistance and enhanced viral replication in vitro. Antimicrob Agents Chemother 2007, 51:2285-2292. [PubMed: 17438047].
24. Cabezas S., Suárez M., Romero C., Carrillo P., García M., Reátegui S., et al. Hiperendemicidad de hepatitis viral B y Delta en pueblos indígenas de la Amazonía Peruana. Rev Peru Med Exp Salud Pública 2006, 23:114-122.
25. Monsalve-Castillo F., Echeverría J., Atencio R., Suárez A., Estévez J., Costa-León L., et al. High prevalence of hepatitis B infection in Amerindians in Japreira, Zulia State. Venezuela Cad Saúde Pública 2008, 24:1183-1186. [PubMed: 18461250].
26. León P., Venegas E., Bengoechea L., Rojas E., López J., Elola C., et al. Prevalencia de las infecciones por virus de las hepatitis B, C, D y E en Bolivia. Rev Panam Salud Publica 1999, 5:144-151. [PubMed: 10355311].
27. Candotti D., Grabarczyk P., Ghiazza P., Roig R., Casamitjana N., Iudicone P., et al. Characterization of occult hepatitis B virus from blood donors carrying genotype A2 or genotype D strains. J Hepatol 2008, 49:537-547. [PubMed: 18602718].
28. Miura Y., Shibuya A., Adachi S., Takeuchi A., Tsuchihashi T., Nakazawa T., et al. Occult hepatitis B virus infection as a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C in whom viral eradication fails. Hepatol Res 2008, 38:546-556. [PubMed: 18179561].
29. Raimondo G., Navarra G., Mondello S., Costantino L., Colloredo G., Cucinotta E., et al. Occult hepatitis B virus in liver tissue of individuals without hepatic disease. J Hepatol 2008, 48:743-746. [PubMed: 18314221].
30. Zahn A., Li C., Danso K., Candotti D., Owusu-Ofori S., Temple J., et al. Molecular characterization of occult hepatitis B virus in genotype E-infected subjects. J Gen Virol 2008, 89:409-418. [PubMed: 18198371].
31. Raimondo G., Pollicino T., Romanò L., Zanetti A. A 2010 update on occult hepatitis B infection. Pathol Biol (Paris) 2010, 58(4):254-257. [PubMed: 20303674].
32. Candotti D., Allain J.P. Transfusion-transmitted hepatitis B infection. J Hepatol 2009, 51:798-809. [PubMed: 19615780].
33. Li M.S., Lau T.C., Chan S.K., Wong C.H., Ng P.K., Sung J.J., et al. The G1613A mutation in the HBV genome affects HBeAg expression and viral replication through altered core promoter activity. PLoS One 2011, 6(7):e21856. [PubMed: 21814558].
34. Di Lello F.A., Piñeiro Y.L.F.G., Muñoz G., Campos R.H. Diversity of hepatitis B and C viruses in Chile. J Med Virol 2009, 81:1887-1894. [PubMed: 19774690].
35. Venegas M., Muñoz G., Hurtado C., Alvarez L., Velasco M., Villanueva R.A., et al. Prevalence of hepatitis B virus genotypes in chronic carriers in Santiago, Chile. Arch Virol 2008, 153:2129-2132. [PubMed: 18953483].
36. Pezzano S.C., Torres C., Fainboim H.A., Bouzas M.B., Schroder T., Giuliano S.F., et al. Hepatitis B virus in Buenos Aires, Argentina: genotypes, virological characteristics and clinical outcomes. Clin Microbiol Infect 2011, 17:223-231. [PubMed: 20545965].
37. Zoulim F., Locarnini S. Hepatitis B virus resistance to nucleos(t)ide analogues. Gastroenterology 2009, 137:1593-1608. [PubMed: 19737565].
38. Bottecchia M., Madejon A., Sheldon J., Garcia-Samaniego J., Barreiro P., Soriano V., et al. B virus genotype A2 harbours an L217R polymorphism which may account for a lower response to adefovir. J Antimicrob Chemother 2008, 62:626-627. [PubMed: 18467302].
39. Cuestas M.L., Rivero C.W., Minassian M.L., Castillo A.I., Gentile E.A., Trinks J., et al. Naturally occurring hepatitis B virus (HBV) variants with primary resistance to antiviral therapy and S-mutants with potential primary resistance to adefovir in Argentina. Antiviral Res 2010, 87:74-77. [PubMed: 20403388].
40. Zöllner B., Sterneck M., Wursthorn K., Petersen J., Schröter M., Laufs R., et al. Prevalence, incidence, and clinical relevance of the reverse transcriptase V207I mutation outside the YMDD motif of the hepatitis B virus polymerase during lamivudine therapy. J Clin Microbiol 2005, 43:2503-2505. [PubMed: 15872296].
41. Schildgen V., Ziegler S., Tillmann R.L., Schildgen O. Novel mutation in YMDD motif and direct neighbourhood in a child with chronic HBV-infection and clinical lamivudine and adefovir resistance - a scholarly case. Virol J 2010, 21(7):167. [PubMed: 20646332].
42. Das K., Xiong X., Yang H., Westland C.E., Gibbs C.S., Sarafianos S.G., et al. Molecular modeling and biochemical characterization reveal the mechanism of hepatitis B virus polymerase resistance to lamivudine (3TC) and emtricitabine (FTC). J Virol 2001, 75(10):4771-4779. [PubMed: 11312349].